GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » OrganiGram Holdings Inc (TSX:OGI) » Definitions » EBITDA Margin %

OrganiGram Holdings (TSX:OGI) EBITDA Margin % : -63.54% (As of Mar. 2024)


View and export this data going back to 2011. Start your Free Trial

What is OrganiGram Holdings EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. OrganiGram Holdings's EBITDA for the three months ended in Mar. 2024 was C$-23.9 Mil. OrganiGram Holdings's Revenue for the three months ended in Mar. 2024 was C$37.6 Mil. Therefore, OrganiGram Holdings's EBITDA margin for the quarter that ended in Mar. 2024 was -63.54%.


OrganiGram Holdings EBITDA Margin % Historical Data

The historical data trend for OrganiGram Holdings's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OrganiGram Holdings EBITDA Margin % Chart

OrganiGram Holdings Annual Data
Trend Apr12 Apr13 Apr14 Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -166.88 333.08 15.79 -141.32 -122.17

OrganiGram Holdings Quarterly Data
Feb19 May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Dec23 Mar24
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 27.56 -1.24 -633.40 -35.29 -63.54

Competitive Comparison of OrganiGram Holdings's EBITDA Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, OrganiGram Holdings's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


OrganiGram Holdings's EBITDA Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, OrganiGram Holdings's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where OrganiGram Holdings's EBITDA Margin % falls into.



OrganiGram Holdings EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

OrganiGram Holdings's EBITDA Margin % for the fiscal year that ended in Aug. 2021 is calculated as

EBITDA Margin %=EBITDA (A: Aug. 2021 )/Revenue (A: Aug. 2021 )
=-96.711/79.163
=-122.17 %

OrganiGram Holdings's EBITDA Margin % for the quarter that ended in Mar. 2024 is calculated as

EBITDA Margin %=EBITDA (Q: Mar. 2024 )/Revenue (Q: Mar. 2024 )
=-23.91/37.628
=-63.54 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


OrganiGram Holdings  (TSX:OGI) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


OrganiGram Holdings EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of OrganiGram Holdings's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


OrganiGram Holdings (TSX:OGI) Business Description

Traded in Other Exchanges
Address
145 King Street West, Suite 1400, Toronto, ON, CAN, M5H 1J8
OrganiGram Holdings Inc is engaged in producing indoor-grown cannabis for patients and adult recreational consumers in Canada. The company has also developed a portfolio of adult-use recreational cannabis brands including Edison, Big Bag o' Buds, SHRED, Monjour, Holy Mountain, and Trailblazer. Tremblant Cannabis, and artisanal craft brand, Laurentian are recent additions to Organigram's existing brand portfolio.
Executives
Donald Geoffrey Machum Director